Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 1
2023 1
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Nationwide treatment and outcomes of intrahepatic cholangiocarcinoma.
Olthof PB, Franssen S, van Keulen AM, van der Geest LG, Hoogwater FJH, Coenraad M, van Driel LMJW, Erdmann JI, Mohammad NH, Heij L, Klümpen HJ, Tjwa E, Valkenburg-van Iersel L, Verheij J, Groot Koerkamp B; Dutch Hepatocellular & Cholangiocarcinoma Group (DHCG). Olthof PB, et al. HPB (Oxford). 2023 Nov;25(11):1329-1336. doi: 10.1016/j.hpb.2023.06.019. Epub 2023 Jul 17. HPB (Oxford). 2023. PMID: 37532665 Free article.
Nationwide treatment and outcomes of perihilar cholangiocarcinoma.
van Keulen AM, Franssen S, van der Geest LG, de Boer MT, Coenraad M, van Driel LMJW, Erdmann JI, Haj Mohammad N, Heij L, Klümpen HJ, Tjwa E, Valkenburg-van Iersel L, Verheij J, Groot Koerkamp B, Olthof PB; Dutch Hepatocellular & Cholangiocarcinoma Group (DHCG). van Keulen AM, et al. Liver Int. 2021 Aug;41(8):1945-1953. doi: 10.1111/liv.14856. Epub 2021 Mar 12. Liver Int. 2021. PMID: 33641214 Free PMC article.
Impact of COVID-19 on Incidence, Treatment, and Survival of Patients with Hepatocellular Carcinoma in the Netherlands.
Furumaya A, van Delden OM, de Wilde RF, de Vos-Geelen J, van der Geest LG; Dutch Hepatocellular & Cholangiocarcinoma Group (DHCG) and the COVID & Cancer-NL consortium. Furumaya A, et al. Disaster Med Public Health Prep. 2024 Oct 30;18:e243. doi: 10.1017/dmp.2024.176. Disaster Med Public Health Prep. 2024. PMID: 39473387
OBJECTIVE: The impact of the coronavirus disease 2019 (COVID-19) on hepatocellular carcinoma (HCC) care is unclear. This study reports on HCC patterns during the COVID-19 pandemic in the Netherlands. ...
OBJECTIVE: The impact of the coronavirus disease 2019 (COVID-19) on hepatocellular carcinoma (HCC) care is unclear. This study report …
Trends in incidence, diagnosis, treatment and survival of hepatocellular carcinoma in a low-incidence country: Data from the Netherlands in the period 2009-2016.
Reinders MTM, van Meer S, Burgmans MC, de Jong KP, Klümpen HJ, de Man RA, Ramsoekh DS, Sprengers D, Tjwa ETTL, de Vos-Geelen J, van Erpecum KJ, van der Geest LGM; Dutch Hepatocellular & Cholangiocarcinoma Group (DHCG). Reinders MTM, et al. Eur J Cancer. 2020 Sep;137:214-223. doi: 10.1016/j.ejca.2020.07.008. Epub 2020 Aug 13. Eur J Cancer. 2020. PMID: 32799035
OBJECTIVE: Evaluation of the trends in incidence, diagnostics, treatment and survival of patients with hepatocellular carcinoma (HCC) in the Netherlands. METHOD: Data regarding incidence, diagnostics, primary treatment and survival of patients with HCC in the period 2009-2 …
OBJECTIVE: Evaluation of the trends in incidence, diagnostics, treatment and survival of patients with hepatocellular carcinoma (HCC) …